Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor

Christine Longuet, Ana M. Robledo, E. Danielle Dean, Chunhua Dai, Safina Ali, Ian McGuinness, Vincent De Chavez, Patricia M. Vuguin, Maureen J. Charron, Alvin C. Powers, Daniel J. Drucker

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Glucagon is a critical regulator of glucose homeostasis; however, mechanisms regulating glucagon action and α-Cell function and number are incompletely understood. To elucidate the role of the hepatic glucagon receptor (Gcgr) in glucagon action, we generated mice with hepatocyte-specific deletion of the glucagon receptor. GcgrHep-/- mice exhibited reductions in fasting blood glucose and improvements in insulin sensitivity and glucose tolerance compared with wild-type controls, similar in magnitude to changes observed in Gcgr-/- mice. Despite preservation of islet Gcgr signaling, GcgrHep-/- mice developed hyperglucagonemia and α-Cell hyperplasia. To investigate mechanisms by which signaling through the Gcgr regulates α-Cell mass, wild-type islets were transplanted into Gcgr-/- or GcgrHep-/- mice. Wild-type islets beneath the renal capsule of Gcgr-/- or GcgrHep-/- mice exhibited an increased rate of α-Cell proliferation and expansion of α-Cell area, consistent with changes exhibited by endogenous α-Cells in Gcgr -/- and GcgrHep-/- pancreata. These results suggest that a circulating factor generated after disruption of hepatic Gcgr signaling can increase α-Cell proliferation independent of direct pancreatic input. Identification of novel factors regulating α-Cell proliferation and mass may facilitate the generation and expansion of α-Cells for transdifferentiation into β-cells and the treatment of diabetes.

Original languageEnglish (US)
Pages (from-to)1196-1205
Number of pages10
JournalDiabetes
Volume62
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Glucagon Receptors
Hyperplasia
Intercellular Signaling Peptides and Proteins
Liver
Glucagon
Cell Proliferation
Cell Transdifferentiation
Glucose
Capsules
Insulin Resistance
Blood Glucose
Pancreas
Hepatocytes
Fasting
Homeostasis
Cell Count

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Longuet, C., Robledo, A. M., Dean, E. D., Dai, C., Ali, S., McGuinness, I., ... Drucker, D. J. (2013). Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor. Diabetes, 62(4), 1196-1205. https://doi.org/10.2337/db11-1605

Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor. / Longuet, Christine; Robledo, Ana M.; Dean, E. Danielle; Dai, Chunhua; Ali, Safina; McGuinness, Ian; De Chavez, Vincent; Vuguin, Patricia M.; Charron, Maureen J.; Powers, Alvin C.; Drucker, Daniel J.

In: Diabetes, Vol. 62, No. 4, 04.2013, p. 1196-1205.

Research output: Contribution to journalArticle

Longuet, C, Robledo, AM, Dean, ED, Dai, C, Ali, S, McGuinness, I, De Chavez, V, Vuguin, PM, Charron, MJ, Powers, AC & Drucker, DJ 2013, 'Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor', Diabetes, vol. 62, no. 4, pp. 1196-1205. https://doi.org/10.2337/db11-1605
Longuet, Christine ; Robledo, Ana M. ; Dean, E. Danielle ; Dai, Chunhua ; Ali, Safina ; McGuinness, Ian ; De Chavez, Vincent ; Vuguin, Patricia M. ; Charron, Maureen J. ; Powers, Alvin C. ; Drucker, Daniel J. / Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor. In: Diabetes. 2013 ; Vol. 62, No. 4. pp. 1196-1205.
@article{68c3d515fa914ce19f3fce86d6236f93,
title = "Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor",
abstract = "Glucagon is a critical regulator of glucose homeostasis; however, mechanisms regulating glucagon action and α-Cell function and number are incompletely understood. To elucidate the role of the hepatic glucagon receptor (Gcgr) in glucagon action, we generated mice with hepatocyte-specific deletion of the glucagon receptor. GcgrHep-/- mice exhibited reductions in fasting blood glucose and improvements in insulin sensitivity and glucose tolerance compared with wild-type controls, similar in magnitude to changes observed in Gcgr-/- mice. Despite preservation of islet Gcgr signaling, GcgrHep-/- mice developed hyperglucagonemia and α-Cell hyperplasia. To investigate mechanisms by which signaling through the Gcgr regulates α-Cell mass, wild-type islets were transplanted into Gcgr-/- or GcgrHep-/- mice. Wild-type islets beneath the renal capsule of Gcgr-/- or GcgrHep-/- mice exhibited an increased rate of α-Cell proliferation and expansion of α-Cell area, consistent with changes exhibited by endogenous α-Cells in Gcgr -/- and GcgrHep-/- pancreata. These results suggest that a circulating factor generated after disruption of hepatic Gcgr signaling can increase α-Cell proliferation independent of direct pancreatic input. Identification of novel factors regulating α-Cell proliferation and mass may facilitate the generation and expansion of α-Cells for transdifferentiation into β-cells and the treatment of diabetes.",
author = "Christine Longuet and Robledo, {Ana M.} and Dean, {E. Danielle} and Chunhua Dai and Safina Ali and Ian McGuinness and {De Chavez}, Vincent and Vuguin, {Patricia M.} and Charron, {Maureen J.} and Powers, {Alvin C.} and Drucker, {Daniel J.}",
year = "2013",
month = "4",
doi = "10.2337/db11-1605",
language = "English (US)",
volume = "62",
pages = "1196--1205",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia evidence for a circulating α-Cell Growth Factor

AU - Longuet, Christine

AU - Robledo, Ana M.

AU - Dean, E. Danielle

AU - Dai, Chunhua

AU - Ali, Safina

AU - McGuinness, Ian

AU - De Chavez, Vincent

AU - Vuguin, Patricia M.

AU - Charron, Maureen J.

AU - Powers, Alvin C.

AU - Drucker, Daniel J.

PY - 2013/4

Y1 - 2013/4

N2 - Glucagon is a critical regulator of glucose homeostasis; however, mechanisms regulating glucagon action and α-Cell function and number are incompletely understood. To elucidate the role of the hepatic glucagon receptor (Gcgr) in glucagon action, we generated mice with hepatocyte-specific deletion of the glucagon receptor. GcgrHep-/- mice exhibited reductions in fasting blood glucose and improvements in insulin sensitivity and glucose tolerance compared with wild-type controls, similar in magnitude to changes observed in Gcgr-/- mice. Despite preservation of islet Gcgr signaling, GcgrHep-/- mice developed hyperglucagonemia and α-Cell hyperplasia. To investigate mechanisms by which signaling through the Gcgr regulates α-Cell mass, wild-type islets were transplanted into Gcgr-/- or GcgrHep-/- mice. Wild-type islets beneath the renal capsule of Gcgr-/- or GcgrHep-/- mice exhibited an increased rate of α-Cell proliferation and expansion of α-Cell area, consistent with changes exhibited by endogenous α-Cells in Gcgr -/- and GcgrHep-/- pancreata. These results suggest that a circulating factor generated after disruption of hepatic Gcgr signaling can increase α-Cell proliferation independent of direct pancreatic input. Identification of novel factors regulating α-Cell proliferation and mass may facilitate the generation and expansion of α-Cells for transdifferentiation into β-cells and the treatment of diabetes.

AB - Glucagon is a critical regulator of glucose homeostasis; however, mechanisms regulating glucagon action and α-Cell function and number are incompletely understood. To elucidate the role of the hepatic glucagon receptor (Gcgr) in glucagon action, we generated mice with hepatocyte-specific deletion of the glucagon receptor. GcgrHep-/- mice exhibited reductions in fasting blood glucose and improvements in insulin sensitivity and glucose tolerance compared with wild-type controls, similar in magnitude to changes observed in Gcgr-/- mice. Despite preservation of islet Gcgr signaling, GcgrHep-/- mice developed hyperglucagonemia and α-Cell hyperplasia. To investigate mechanisms by which signaling through the Gcgr regulates α-Cell mass, wild-type islets were transplanted into Gcgr-/- or GcgrHep-/- mice. Wild-type islets beneath the renal capsule of Gcgr-/- or GcgrHep-/- mice exhibited an increased rate of α-Cell proliferation and expansion of α-Cell area, consistent with changes exhibited by endogenous α-Cells in Gcgr -/- and GcgrHep-/- pancreata. These results suggest that a circulating factor generated after disruption of hepatic Gcgr signaling can increase α-Cell proliferation independent of direct pancreatic input. Identification of novel factors regulating α-Cell proliferation and mass may facilitate the generation and expansion of α-Cells for transdifferentiation into β-cells and the treatment of diabetes.

UR - http://www.scopus.com/inward/record.url?scp=84875478761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875478761&partnerID=8YFLogxK

U2 - 10.2337/db11-1605

DO - 10.2337/db11-1605

M3 - Article

C2 - 23160527

AN - SCOPUS:84875478761

VL - 62

SP - 1196

EP - 1205

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -